Tumor growth rate for prognostic stratification and treatment optimization in unresectable hepatocellular carcinoma treated with TACE combined with systemic therapy

Abstract Background Tumor growth rate (TGR) is a dynamic biomarker for evaluating therapeutic response and prognosis in unresectable hepatocellular carcinoma (uHCC) with triple therapy, yet its clinical utility and role in guiding treatment optimization require further validation. Methods This study...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Guobin Chen, Meixia Wang, Xing Huang, Zhenzhen Zhang, Yanfang Wu, Xiaochun Chen, Xinkun Guo, Susu Zheng, Tanghui Zheng, Hong Chen, Jingfang Wu, Boheng Zhang
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2026-01-01
Serie:	BMC Gastroenterology
Soggetti:	Hepatocellular carcinoma Tumor growth rate Transarterial chemoembolization Immune checkpoint inhibitors Angiogenesis inhibitors
Accesso online:	https://doi.org/10.1186/s12876-025-04596-2
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!